GET DAILY SIGNALSAmbiq (AMBQ) Delivers Solid Q3 2026 Results with +110% Revenue Growth
Key Takeaways
- Net sales reached $38.1 million, up 110% year over year, marking Ambiq's sixth consecutive quarter of sequential growth.
- Non-GAAP net loss narrowed to $1.2 million, or $0.05 per share, beating consensus estimates by a wide margin.
- Non-GAAP gross margin expanded 390 basis points (3.9 percentage points) year over year to 48.7%.
- Management raised full-year 2026 revenue guidance to roughly $140 million and guided fourth-quarter sales to $43.5 million to $44.5 million.
- Customer diversification improved sharply, with sales outside the company's largest customers rising more than 270% year over year.
- Ambiq ended the quarter with $363.5 million in cash and no debt.
Understanding Ambiq's Business and the Quarter's Importance
Ambiq Micro develops ultra-low-power system-on-chip semiconductors based on its SPOT platform. These chips enable on-device edge AI processing in battery-powered devices. Since the company went public in July 2025, investors have been monitoring whether the strong growth trajectory can continue. The Q3 2026 results provide a useful test of management's ability to manage supply constraints while improving margins and broadening the customer base beyond wearables. I also checked this using Tickeron’s AI Screener to compare the stock against peers.
Breaking Down the Reported Figures
Ambiq posted third-quarter 2026 net sales of $38.1 million, representing a 110% year-over-year increase and coming in above the company's guidance range of $36 million to $37 million. Revenue also topped the consensus estimate of roughly $37.3 million. On a non-GAAP basis, the net loss narrowed to $1.2 million, or $0.05 per share, a clear improvement from the prior year and well ahead of the expected $0.16 per-share loss.
Non-GAAP gross margin rose 390 basis points to 48.7%, reflecting better manufacturing efficiencies and a shift toward higher-value products. Revenue from customers outside the top accounts grew more than 270% year over year, and seven customers each contributed over $1 million, up from three in the prior-year period. The balance sheet remained strong, with $363.5 million in cash and no debt. For the fourth quarter, management expects sales of $43.5 million to $44.5 million and a non-GAAP loss per share between $0.09 and $0.03. Full-year 2026 revenue guidance was raised to approximately $140 million.
Investor Response and Sentiment
Expectations ahead of the report were positive, helped by a string of quarterly beats and rising demand for edge AI solutions. Shares of AMBQ rose after the release as the company exceeded estimates on both revenue and earnings per share while lifting its full-year outlook. Attention now centers on the ability to secure adequate wafer and packaging capacity amid tight supply conditions and on the sustainability of gross margins. Management noted that demand appears driven by real end-market use rather than inventory buildup, which supports a constructive view, although supply limitations and higher operating expenses remain key risks.
Looking Ahead and Items to Watch
The fourth-quarter sales guidance implies about 112% year-over-year growth at the midpoint and would mark a seventh straight quarter of sequential improvement. This outlook rests on solid order trends and low inventory levels in the channel. Supply remains a focal point, as executives noted some short-lead-time demand went unmet and input costs continue to rise even as efficiencies have helped so far. Capacity expansion will be closely followed as demand accelerates into 2027. On the product side, the Atomiq110 platform is on schedule for tape-out by year-end 2026, with sampling expected early in 2027, while the Apollo340 platform should begin sampling next year. These developments, along with further diversification into medical, industrial, and smart-building applications, are the main drivers for growth beyond wearables. Operating expenses are set to increase in the fourth quarter to support multiple programs, and balancing that spending with margin expansion will be critical on the path to profitability.
Refining Analysis with Tickeron Tools
I often turn to Tickeron’s AI-powered resources when evaluating growth stocks like this one. The platform’s pattern recognition and signal features help surface comparable names and highlight potential entry or exit points based on technical and fundamental data. In this case, it provided useful context on how AMBQ stacks up against other semiconductor names and confirmed the strength of the recent momentum. These tools have become a regular part of my workflow for staying objective amid fast-moving earnings seasons.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
AMBQ's RSI Indicator ascending out of oversold territory
The RSI Indicator for AMBQ moved out of oversold territory on November 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 2 similar instances when the indicator left oversold territory. In 2 of the 2 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 10 of 14 cases where AMBQ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
Following a +29.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMBQ advanced for three days, in 52 of 70 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
AMBQ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMBQ as a result. In 18 of 19 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for AMBQ turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 8 similar instances when the indicator turned negative. In 8 of the 8 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
AMBQ moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AMBQ crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 2 of 2 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMBQ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for AMBQ entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.304) is normal, around the industry mean (5.443). P/E Ratio (-8.688) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (14.771) is also within normal values, averaging (46.468).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. AMBQ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMBQ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry Semiconductors
Advertisement